Glenn L. Cooper M.D., Director at REPLIGEN CORP (RGEN), bought 10,000 shares at $6.08 ($61K) on 2012-09-21, disclosed to the SEC on 2012-09-24.
Open-market purchase of $61k RGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.08 | 2,000 | $12K | 20.0% |
| 2 | $6.09 | 3,000 | $18K | 30.0% |
| 3 | $6.09 | 5,000 | $30K | 50.0% |
| Total | $6.09 avg | 10,000 | $61K | 100% |
| Filing → |
| CNDO | BUY | 2012-06-26 | $53K | — | Filing → |
| RGEN | BUY | 2009-11-17 | $25K | — | Filing → |
| IDEV | BUY | 2006-01-09 | $59K | — | Filing → |